A custom home builder in Houston
Digital marketing and website to sell custom homes, and the presale of a new development with its own material.
Ongoing.
Track record
United States HoustonSkin Factor · Global Skin · Seduskin — Seduskin, a professional skincare brand, taken from Mexico to the U.S.: FDA listing, brand and channel, from scratch
Mexico Yvoire and Nabota from zero · LG Chem license
Central America 7 markets · Restylane and Cetaphil
What I do today, outside pharma
Four owner-run businesses I work with as an independent. I’ll give you the names on the call, with each owner’s permission.
A tequila brand
Business and marketing plan, with a commemorative bottle alongside a European football club.
The plan was built with the owner, and I sat in on the conversations with the end customer.
An industrial supplies distributor in Mexico City
Diagnosis, strategy and execution plan to double the business, with its sales numbers and its catalog on the table.
The target is to double it; I’m inside, running the execution with them.
A precision sheet-metal manufacturer in Mexico
Diagnosis, plus a commercial and marketing plan to grow with a global customer.
The diagnosis is done; the commercial and marketing plan is under way.
Restylane and Cetaphil
Regional launch across all seven Central American markets: congresses, in-clinic activation, physician programs. Both went from absent to present in every market.
Opened the door for the rest of the portfolio.
Sinclair
Ellansé and Silhouette Soft, from good product to reference name in collagen biostimulators, with a regional expert panel that certified and trained physicians.
We took share from brands that had been there for years.
Merz
Took a neglected dermatology portfolio.
It got its share, revenue and profit back.
Dituroxal
A launch that arrived with its origin working against it, in a category where the big brands had been entrenched for years.
Started strong and holds a position of its own today.
Dermalink International
Founded and ran a medical-aesthetics company from the ground up. Brought in the exclusive LG Chem license and launched Yvoire and Nabota in a crowded category: positioning, KOL network, clinical-education engine. Nabota came in as the safe, profitable toxin — the first Korean one approved by the FDA.
Competing against Galderma, Merz and Sinclair.
Fifteen years in the operator’s chair
Regional commercial leadership across the U.S., Mexico and Central America — owning P&L, teams and KOL relationships.
First from the corporate side; then with my own company.
What that means for you
It comes down to four things I’ve done and can do again in your business: open a market with a small team, reposition a good product nobody is seeing, rescue something that already exists and nobody is minding, and build demand from scratch.
How I see it
Operated, not theorized
A strategy written by someone who has never had to hit a number is an opinion. I carried the P&L for fifteen years across the U.S., Mexico and Central America, with a team and a budget of my own. I know what moves a business when the result is yours, and I also know what looks great in a deck and changes nothing.
Depth × AI
I know my category inside out and I work with AI every day, which is why I read a market in days instead of months.